Depression and myocardial infarction. Implications for medical prognosis and options for treatment

Drugs and Aging

Volumn 11, Issue 2, 1997, Pages 111-118

  Cleophas, Ton J M ^a  

^a Merwede Ziekenhuis   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY; BRADYCARDIA; DEPRESSION; DISEASE ASSOCIATION; DYSPEPSIA; HEADACHE; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; INSOMNIA; MOOD; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0030822754     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199711020-00003     Document Type: Review

References (64)

1. Carney RM, Rich MW, Tevelde A. Major depressive disorders in coronary artery disease. Am J Cardiol 1987; 60: 1273-5
2. Schleifer SJ, Macari-Hinson MM, Coyle DA. The nature and course of depression following myocardial infarction. Arch Intern Med 1989; 149: 1785-9
3. de Groot PA. Consensus depression in adults. Ned Tijdschr Geneeskd 1995; 139: 1237-41
4. Ruberman W, Weinblatt E, Goldberg JD. Psychosocial influences on mortality after myocardial infarction. N Engl J Med 1989; 311: 552-4
5. Cleophas AJM, de Jong J, Niemeyer MG, et al. Changes in life-style in men under sixty years of age before and after myocardial infarction: a case-control study. Angiology 1993; 44: 761-70
6. Kop WJ, Appels AP, Mendes deLeon CF, et al. Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom Med 1994; 56: 281-7
7. Honig A, Lousberg R, Wojciechowski FL, et al. Depression after first myocardial infarction: difference from ordinary depression. Ned Tijdschr Geneeskd 1997; 141: 196-9
8. Vasquez-Barquero JL, Padierno Acero JA, Ochoteco A, et al. Mental illness and ischemic heart disease: analysis of psychiatric morbidity. Gen Hosp Psychiatry 1985; 7: 15-20
9. Frasure-Smith N, Lespérancc F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91: 999-1005
10. Ahern DK, Gorkin L, Anderson JL. Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol 1990; 66: 50-62
11. Frasure-Smith N. In-hospital symptoms of psychological stress as predictors of long-term outcome after acute myocardial infarction in men. Am J Cardiol 1991; 67: 121-7
12. Frasure-Smith N, Lespérance T, Talajic M. Depression following myocardial infarction. JAMA 1993; 270: 1819-25
13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. rev. Washington, DC: American Psychiatric Association. 1987
14. Ladwig KH, Roll G, Breithardt G, et al. Postinfarction depression and incomplete recovery 6 months after acute myocardial infarction. Lancet 1994; 343: 20-3
15. Ladwig KH, Kieser M, Konig J, et al. Affective disorders and survival after acute myocardial infarction: results from the post-infarction late potential study. Eur Heart J 1991; 12: 959-64
16. Travella JI, Forrester AW, Schultz SK, et al. Depression following myocardial infarction: a one year longitudinal study. Int J Psychiatry Med 1994; 24: 357-69
17. Cleophas TJM. Depression and survival following myocardial infarction [letter]. JAMA 1994; 271: 1081
18. Cleophas TJM, Post-infarction depression [letter]. Lancet 1994; 343: 680
19. Denollet J, Sys SU, Stroobant N, et al. Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet 1996; 347: 417-21
20. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996; 93: 1976-80
21. Pratt LA, Ford DE, Crum RM, et al. Depression, and the risk of myocardial infarction. Circulation 1996; 94: 3123-9
22. Carney RM. Depression and the heart. JAMA 1996; 276: 1123
23. Minneman KP. Pharmacological organization of the rentral nervous system. In: Brody TM, Larser J, Minneman KP, et al., editors. Human pharmacology. New York: Mosby. 1994: 293-320
24. Bennett JP. Drugs for affective (mood) disorders. In: Brody TM, Larser J, Minneman KP, et al., editors. Human pharmacology. New York: Mosby. 1994: 333-43
25. Kleiger RE, Miller JP, Bigger JT, et al. Decreased heart rate variability and its association with mortality after myocardial infarction. Am J Cardiol 1987; 59: 256-62
26. Carney RM, Rich M, teVelde A. The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease. J Psychosom Res 1988; 32: 159-64
27. Dalack GW, Roose SP. Perspectives on the relationship between cardiovascular disease and affective disorder. J Clin Psychiatry 1990; 51 Suppl.: 4-9; discussion 10-1
28. Johnson DB, Dell Italia LJ. Cardiac hypertrophy and failure in hypertension. Curr Opin Nephrol Hypertens 1996; 5: 186-91
29. Ferrara N, Bunting SA. Vascular endothelial growth factor, a specific regulator of angiogenesis. Curr Opin Nephrol Hypertens 1996; 5: 35-45
30. Amann K, Ritz E. Cardiac structure and function in renal disease. Curr Opin Nephrol Hypertens 1996; 5: 102-6
31. Meltzer H, Lowy MT. The serotonin hypothesis of depression. In: Meltzer HY, editor. Psychopharmacology: the third generation of progress. New York: Raven Press. 1987: 513-26
32. Vanhoutte PM. Platelet-derived serotonin, the endothelium, and cardiovascular disease. J Cardiovasc Pharmacol 1991; 17 Suppl. 5: 6-12
33. Meltzer HY, Arora RC. Platelet serotonin studies in affective disorders: evidence for a serotonergic abnormality? In: Sandler M, Coppen A, Harnett S. editors. 5-Hydroxytryptamine in psychiatry. Oxford: Oxford University Press. 1991: 50-89
34. Blumenthal JA, Fredrikson M, Kuhn CM, et al. Aerobic exercise reduces levels of cardiovascular and sympathoadrenal responses to mental stress in subjects without prior evidence of myocardial ischemia. Am J Cardiol 1990; 65: 93-8
35. Stern TA. Psychiatric management of acute myocardial infarction in the coronary care unit. Am J Cardiol 1987; 60: 59J-67J
36. Wardle J, Armitage J, Collins R, Effect on mood of lowering cholesterol concentration. BMJ 1996; 313: 75-8
37. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ 1990; 301: 309-14
38. Lindberg G, Rastam L, Gulberg B, et al. Low serum cholesterol concentration and short term mortality from injuries in men and women. BMJ 1992; 305: 277-9
39. Nealon JD, Blackburn H, Jacobs D, et al. Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial. Arch Intern Med 1992; 152: 1490-500
40. Engelberg H. Low scrum cholesterol and suicide. Lancet 1992; 339: 727-9
41. Barrett-Connor E, Palinkas LA. Low blood pressure and depression in older men: a population based study, BMJ 1994; 308: 446-9
42. Pyszynsky T, Grunberg J. Selfregulation, perseveration and the depression self-focusing style: a self-awareness theory of reactive depression. Psychol Bull 1987; 102: 122-38
43. Maier W, Lichtermann D, Minges J, et al. Personality traits in subjects at risk for unipolar major depression: a family study perspective. J Affect Disord 1992; 24: 153-63
44. Mendels J. The acute and long-term treatment of major depression. Int Clin Psychopharmacol 1992; 7 Suppl. 2: 21-9
45. Hance M, Carney RM, Freedland KE, et al. Depression in patients with coronary heart disease: a twelve month follow-up. Gen Hosp Psychiatry 1995; 18: 61-5
46. Lespérance F, Frasure-Smith N, Talajic M. Major depression after myocardial infarction: its nature and consequences. Psychosom Med 1996; 58: 99-110
47. Roose SP, Classman AH, Attia E, et al. Comparative efficacy of the specific serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994; 151: 1735-9
48. Greene HL, Roden DM, Katz RJ. The Cardiac Arrhythmia Suppression Trial: first CAST. . . then CAST II. J Am Coll Cardiol 1992; 19: 804-8
49. Cardiac Arrhythmia Suppression Trial II (CAST II) Investigators, Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992; 327: 227-33
50. Echt DS, Liebson PB, Mitchell LB, Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324: 781-8
51. Roose SP, Glassman AM. Antidepressant choice in the patient with cardiac disease: lessons from the Cardiac Arrhythmia Suppression Trial studies. J Clin Psychiatry 1994; 55 Suppl. A: 83-7; discussion 88-9, 98-100
52. Greene LF. Fluoxetine. N Engl J Med 1994; 331: 1354-61
53. Walley T, Pirmohamed M, Proudlove C, et al. Interaction of metoprolol and fluoxetine. Lancet 1993; 341: 967-8
54. Sternbach H, Danger of antidepressant therapy after fluoxetine withdrawal. Lancet 1988; II: 850-1
55. Darga LL, Carroll-Michals L, Botsford SJ, et al. Fluoxetine's effect on weight loss in obese subjects. Am J Clin Nutr 1991; 54: 321-5
56. Walsh BT. Fluoxetine treatment of bulimia nervosa. J Psychosom Res 1991; 35 Suppl. 1: 33-40
57. Kaye WH, Weltzin TE, Hsu LKG, et al. An open trial of fluoxetine in patients with anorexia nervosa. J Clin Psychiatry 1991; 52: 464-71
58. Sindrup SH, Bjerre U, Dejgaard A, et al. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther 1992; 52: 547-52
59. Stone AB, Pearlstein TB, Brown WA. Fluoxetine in the treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 1991; 52: 290-3
60. Menkes DB, Taghavi E, Mason PA, et al. Fluoxetine treatment of severe premenstrual syndrome, BMJ 1992; 305: 346-7
61. Cleophas TJ, Tuinenberg E, van der Meulen J, et al. Wine consumption and other dietary variables in males under 60 before and after myocardial infarction. Angiology 1996; 47: 789-96
62. Pérez-Stable EJ, Miranda J, Munoz RF, et al. Depression in medical outpatients: underrecognition and misdiagnosis. Arch Intern Med 1990; 150: 1083-8
63. Lansberg L. Treating depression in medical conditions may improve quality of life. JAMA 1996; 276: 857-8
64. Gundy P. Depression and the heart. JAMA 1996; 276: 1123-4